Drawbridge Health today announced it received 510(k) clearance from the United States Food and Drug Administration (FDA) for the OneDraw™ A1C
Senseonics Holdings, Inc., announced that they received FDA approval for the non-adjunctive indication (dosing claim) for the Eversense Continuous
DarioHealth Corp., a digital Therapeutics company, announced today the receipt of a license from Health Canada to sell its Dario™ Blood
POPS! Diabetes Care announced the commercial launch of their POPS!® one diabetes management system following FDA clearance in November.
Dexcom, Inc. announced last week that the company has received Health Canada approval for its next-generation Dexcom G6 CGM System for people with
The U.S. Food and Drug Administration (FDA) today permitted marketing of the Tandem Diabetes Care t:Slim X2 insulin pump with interoperable
Ascensia Diabetes Care announced earlier this month that it has entered into a global alliance with Zhejiang POCTech, Co., Ltd, a Chinese company
POPS! Diabetes Care received U.S. Food and Drug Administration (FDA) clearance of their POPS!® one Blood Glucose Monitoring System yesterday.
Diabeloop announced this month it has received the CE marking for its “artificial pancreas system,” dubbed the DBLG1,™ for adults
Tandem Diabetes Care®, Inc., a medical device company and manufacturer of the only touchscreen insulin pumps with continuous glucose monitoring
Get a little dLife delivered to your inbox every week.
Leave this field empty if you’re human: